Welcome to the OMA Blog

SSRIs are widely prescribed, but their metabolic effects vary by drug and patient. Here's what clinicians need to know about SSRIs and weight gain.

A clinical overview of the bidirectional relationship between obesity and kidney disease, covering underlying mechanisms, screening protocols, and treatment approaches for obesity medicine providers.

Weight loss medications have undergone a sea change in the past several years. With the rise of incretin therapies, two names have emerged as leaders: tirzepatide and semaglutide. They share many similarities. The frequency with which we hear these two drug names bandied about, along with their brand names — Mounjaro/Zepbound and Ozempic/Wegovy, respectively — can lead to confusion.

The hypothalamus may be small, but its influence on human physiology is profound. As a central regulator of neuroendocrine function, it plays a critical role in maintaining homeostasis—coordinating hunger and satiety, energy expenditure, sleep–wake cycles, thermoregulation, thirst, and fatigue.1-4 When this finely tuned system is disrupted, the downstream clinical consequences can be severe and lifelong.

Learn how a low carb diet supports obesity treatment. Explore carbohydrate definitions, sex-specific metabolic effects, and clinical risks.

Learn about metabolic flexibility and its role in obesity treatment in this in-depth guide for healthcare providers.

Obesity is no longer a looming public health threat—it is a full-scale epidemic. More than 40% of U.S. adults live with obesity,1 driving increased risk of type 2 diabetes, cardiovascular-kidney metabolic disease, and reduced quality of life and life expectancy.

The Obesity Medicine Association (OMA) supports many aspects of the new Dietary Guidelines for Americans , including: A strong emphasis on reducing intake of ultra-processed foods and added sugars A focus on nutrient-dense foods containing fiber, including fruits, vegetables, and whole grains The recommendation to limit saturated fat intake to no more than 10% of total daily calories and to prioritize healthier unsaturated fats Emerging evidence highlighting the importance of nutrition in supporting gut microbiome health Support for extended breastfeeding as beneficial to both maternal and child health At the same time, the OMA emphasizes that obesity is a chronic, relapsing and progressive disease process affecting weight homeostasis.

Learn how non-exercise activity thermogenesis (NEAT) supports obesity treatment and explore clinical guidance to boost patient outcomes.